- Home
- RVTY vs NBIX Comparison
RVTY vs NBIX Comparison
Compare RVTY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- NBIX
- Stock Information
- Founded
- RVTY 1937
- NBIX 1992
- Country
- RVTY United States
- NBIX United States
- Employees
- RVTY N/A
- NBIX N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVTY Industrials
- NBIX Health Care
- Exchange
- RVTY Nasdaq
- NBIX Nasdaq
- Market Cap
- RVTY 11.4B
- NBIX 13.2B
- IPO Year
- RVTY N/A
- NBIX 1996
- Fundamental
- Price
- RVTY $88.18
- NBIX $128.91
- Analyst Decision
- RVTY Buy
- NBIX Strong Buy
- Analyst Count
- RVTY 14
- NBIX 22
- Target Price
- RVTY $121.86
- NBIX $165.59
- AVG Volume (30 Days)
- RVTY 1.6M
- NBIX 935.9K
- Earning Date
- RVTY 07-28-2025
- NBIX 07-30-2025
- Dividend Yield
- RVTY 0.32%
- NBIX N/A
- EPS Growth
- RVTY 72.56
- NBIX 2.97
- EPS
- RVTY 2.37
- NBIX 3.39
- Revenue
- RVTY $2,798,467,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- RVTY $5.55
- NBIX $16.12
- Revenue Next Year
- RVTY $5.54
- NBIX $15.06
- P/E Ratio
- RVTY $37.28
- NBIX $38.04
- Revenue Growth
- RVTY 3.33
- NBIX 18.42
- 52 Week Low
- RVTY $85.84
- NBIX $84.23
- 52 Week High
- RVTY $129.50
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- RVTY 37.97
- NBIX 46.34
- Support Level
- RVTY $92.62
- NBIX $130.75
- Resistance Level
- RVTY $97.13
- NBIX $137.44
- Average True Range (ATR)
- RVTY 3.50
- NBIX 3.60
- MACD
- RVTY -1.20
- NBIX -0.71
- Stochastic Oscillator
- RVTY 12.79
- NBIX 33.88
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.